阿尔凯默斯 ALKS 深 沪
已收盘 08-29 16:00:00 美东时间
28.97
+0.040
+0.14%
华盛通- 最 高29.445
- 今 开28.98
- 成交量 142.67万股
- 最 低 28.895
- 昨 收 28.93
- 总市值 47.80亿
- 52周最高 36.45
- 市盈率 静 13.35
- 换手率 0.86%
- 52周最低 25.56
- 委 比 62.81%
- 总股本 1.65亿
- 历史最高 79.041
- 量 比 1.16
- 振 幅 1.90%
- 历史最低 10.311
- 每 手 1
- 风险率 2.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alkermes To Present Detailed Results From Its Vibrance-1 Phase 2 Study Evaluating Alixorexton In Patients With Narcolepsy Type 1 At World Sleep Congress
Results From Vibrance-1 to Be Shared in Three Oral Presentations, Including Primary and Secondary Efficacy and Safety Measures, and Exploratory Patient-Reported Outcomes Related to Disease Severity, Fatigue and Cognition
08-25 19:07
Earnings Outlook For Krystal Biotech
Krystal Biotech (NASDAQ:KRYS) is set to give its latest quarterly earnings repo...
08-02 03:01
Alkermes shares are trading higher after the company reported better-than-expected Q2 financial results. Needham reiterated a Buy rating on the stock.
Alkermes shares are trading higher after the company reported better-than-expec...
07-29 21:15
Alkermes Affirms FY2025 GAAP EPS Guidance of $1.03-$1.21 vs $1.15 Est; Affirms FY2025 Sales Guidance of $1.340B-$1.430B vs $1.385B Est
Alkermes (NASDAQ:ALKS) affirms FY2025 GAAP EPS guidance from $1.03-$1.21 to $1.03-$1.21 vs $1.15 analyst estimate. Affirms FY2025 sales outlook from $1.340 billion-$1.430 billion to $1.340 billion-$1.430 billion vs
07-29 19:06
Alkermes Q2 EPS $0.52 Beats $0.24 Estimate, Sales $390.657M Beat $342.116M Estimate
Alkermes (NASDAQ:ALKS) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.24 by 117.57 percent. This is a 27.78 percent decrease over earnings of $0.72 per share from the same
07-29 19:03
Earnings Scheduled For July 29, 2025
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32
美股大行评级 | 潜在涨幅23.77%！美国运通获德银升目标价至375美元，维持"买入"评级
今日重点评级关注：德银：维持美国运通"买入"评级，目标价从371美元升至375美元；巴克莱：维持Gaming and Leisure Props"标配"评级，目标价从54美元升至55美元
07-22 09:35
Alkermes Announces Positive Phase 2 Study Results
Alkermes ( ($ALKS) ) has shared an update. On July 21, 2025, Alkermes announced...
07-22 05:49
Alkermes shares are trading lower. HC Wainwright & Co. reiterated a Neutral rating on the stock.
Alkermes shares are trading lower. HC Wainwright & Co. reiterated a Neutral...
07-22 00:19
Expert Outlook: Alkermes Through The Eyes Of 6 Analysts
Alkermes (NASDAQ:ALKS) has been analyzed by 6 analysts in the last three months...
07-16 03:01
